News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diagnovus Launches First Comprehensive Genetic Profile For Patients With Diffuse Large B-Cell Lymphoma


12/4/2013 9:51:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHVILLE, Tenn.--(BUSINESS WIRE)--Diagnovus, LLC, a molecular diagnostic company focused on underserved, aggressive and lesser-known diseases, today announced an important addition to its ENGAUGE™ cancer assay portfolio with the launch of the ENGAUGE™-cancer DLBCL Gene Panel, the first commercially available genomic profile to aid physicians in tailoring treatment specifically for patients with diffuse large B-cell lymphoma (DLBCL). The assay is being introduced at the American Society of Hematology Annual Meeting Dec. 7–10, 2013, in New Orleans (Booth #1924).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Diagnovus
 
 
Lymphoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES